Rhenium Skin Cancer Treatment

Rhenium Skin Cancer Treatment

Rhenium-SCT is a non-surgical, single-dose radiotherapy treatment for certain non-melanoma skin cancers, including basal cell carcinoma (BCC) and low-risk squamous cell carcinoma (SCC).

Rhenium-SCT has demonstrated high cure rates and patients reported favourable cosmetic outcomes.

• 98.8% of Australian patients in the EPIC trial achieved a cure

When is Rhenium-SCT Used?

Rhenium-SCT may be considered for certain non-melanoma skin cancers following clinical assessment and confirmation of diagnosis. It may be an option for:

• Skin cancers in surgically difficult areas, including the face, nose, ears, neck and fingers.
• Patients who are unsuitable for or prefer to avoid surgery.
• Patients for whom extended courses of radiotherapy may be impractical.

Learn More About Rhenium-SCT

Find out what to expect before, during and after treatment, including preparation, recovery, potential side effects and frequently asked questions. 

Book a Consultation

Speak with our team about your treatment options and whether Rhenium-SCT may be appropriate for your individual circumstances.